SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/09EF481005301CF24DB2777E6E49D94AED6C9D7FDA063A70EB1676E76CA7C0956C21A45EE24669B55E0DF1A61C187B5D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/09EF481005301CF24DB2777E6E49D94AED6C9D7FDA063A70EB1676E76CA7C0956C21A45EE24669B55E0DF1A61C187B5D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/09EF481005301CF24DB2777E6E49D94AED6C9D7FDA063A70EB1676E76CA7C0956C21A45EE24669B55E0DF1A61C187B5D
http://www.w3.org/2000/01/rdf-schema#comment
"To study HLA-linked adverse drug reactions in vivo we generated HLA-B*57:01-Tg mice and show that although abacavir activated Tg mouse CD8+ T cells in vitro in a HLA-B*57:01-dependent manner the drug was tolerated in vivo."
xsd:string
http://purl.uniprot.org/uniprot/#_4836AFAD03895C6B808E7F85EA9C525C0BBF229AECA3A5A277A548585D8A83388FB34B07720D49FECE54769311A5B6C6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/09EF481005301CF24DB2777E6E49D94AED6C9D7FDA063A70EB1676E76CA7C0956C21A45EE24669B55E0DF1A61C187B5D
http://purl.uniprot.org/uniprot/K9LC40
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/09EF481005301CF24DB2777E6E49D94AED6C9D7FDA063A70EB1676E76CA7C0956C21A45EE24669B55E0DF1A61C187B5D
http://purl.uniprot.org/uniprot/#_K9LC40-mappedCitation-29782330
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/09EF481005301CF24DB2777E6E49D94AED6C9D7FDA063A70EB1676E76CA7C0956C21A45EE24669B55E0DF1A61C187B5D